Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 21, 2017 11:39 ET | Source: Crown Bioscience

Crown Bioscience Announces Merger with JSR Corporation

SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services...
December 20, 2017 09:00 ET | Source: Crown Bioscience

Crown Bioscience International announces Agreement and Plan of Merger with JSR Corporation

SAN DIEGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience International (“CrownBio”) (TWSE:ticker 6554) on December 19, 2017 has entered into the Agreement and Plan of Merger (the “Merger...
December 07, 2017 10:36 ET | Source: Crown Bioscience

Crown Bioscience Releases Scientific Posters Detailing Innovations in Preclinical Cancer Pharmacology

Presentation of Posters by Expert Scientists Now Available On-Demand on Crown Bioscience’s Website https://www.crownbio.com/eortc17-posters SANTA CLARA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) --...
November 23, 2017 08:00 ET | Source: Crown Bioscience

Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring

SANTA CLARA, Calif., Nov. 23, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development...
November 21, 2017 08:00 ET | Source: Crown Bioscience

CrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research Programs

SANTA CLARA, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development...
November 17, 2017 11:53 ET | Source: Crown Bioscience

CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research

SANTA CLARA, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development...
November 09, 2017 05:21 ET | Source: Crown Bioscience

Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results

TAIPEI, Taiwan, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development...
October 19, 2017 08:00 ET | Source: Crown Bioscience

Novel Preclinical Research Tools Provide Humanized Immune Response to Advance Immunotherapeutic Development, Live Webinar Hosted by Crown Bioscience

SANTA CLARA, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development...
October 17, 2017 09:51 ET | Source: Crown Bioscience

Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds at the American Association for Cancer Research’s International Conference on Molecular Targets and Cancer Therapeutics

SANTA CLARA, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development...
October 10, 2017 09:31 ET | Source: Crown Bioscience

CrownBio Enhances Its European Capabilities with New Generation of Innovative Translational Models for Obesity and Diabetes

SANTA CLARA, Calif., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development...